Engineers Gate Manager LP Cure Vac N.V. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $127,599 - $206,543	32,222 New	32,222 $135,000
Q4 2022 Feb 14, 2023	BUY	$5.75 - $8.5 $98,066 - $144,967	17,055 New	17,055 $102,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $510,764 - $752,195	-38,753 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $75,962 - $181,784	5,157 Added 15.35%	38,753 $760,000
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $1.13 Million - $1.62 Million	33,596 New	33,596 $1.15 Million
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $406,690 - $615,072	-8,256 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $469,848 - $1.05 Million	8,256 New	8,256 $607,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.